Author:
Tamegai Hidenori,Kaiga Teruo,Kochi Mitsugu,Fujii Masashi,Kanamori Noriaki,Mihara Yoshiaki,Funada Tomoya,Shimizu Hiroko,Jinno Daijo,Takayama Tadatoshi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference17 articles.
1. Kim YH, Koizumi W, Lee KH, Kishimoto T, Chung HC, Hara T, Cho JY, Nakajima T, Kim H, Fujii M (2011) Randomized phase III study of S-1 alone versus S-1 + docetaxel in the treatment for advanced gastric cancer (The START trial) ASCO-GI 2011 gastrointestinal cancers symposium oral abstract session abstract #7
2. Eguchi T, Fujii M, Wakabayashi K, Aisaki K, Tsuneda Y, Kochi M, Takayama T (2003) Docetaxel plus 5-fluorouracil for terminal gastric cancer patients with peritoneal dissemination. Hepatogastroenterology 50:1735–1738
3. Markman M, Zanotti K, Webster K, Peterson G, Kulp B, Belinson J (2003) Phase 2 trial of single agent docetaxel in platinum and paclitaxel refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. Gynecol Oncol 91(3):573–576
4. Díaz JF, Andreu JM (1993) Assembly of purified GDP-tubulin into microtubules induced by taxol and Taxotere: reversibility, ligand stoichiometry and competition. Biochemistry 32:2747–2755
5. Vasey PA, Jayson GC, Gordon A, Gabra H, Coleman R, Atkinson R, Parkin D, Paul J, Hay A, Kaye SB, Scottish Gynaecological Cancer Trials Group (2004) Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst 96:1682–1691
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献